Observatoire des droits humains (anglais seulement)

US approves twice-yearly injection for HIV prevention – what you need to know about lenacapavir

(Version anglaise seulement)

par Andrew Owen, Molecular and Clinical Pharmacology, University of Liverpool

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new treatment marks a major advancement in expanding prevention options for people at risk of HIV infection.

Most HIV prevention drugs are daily pills (known as PrEP), which many people struggle to take regularly for various reasons,

Lire l'article complet